WCM
ACHV icon

Windsor Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Windsor Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Hold
10,817
– – 0.02% 127
2026
Q1 		$31.8K Hold
10,817
– – 0.01% 123
2025
Q4 		$53.8K Hold
10,817
– – 0.01% 121
2025
Q3 		$34.1K Hold
10,817
– – 0.01% 121
2025
Q2 		$24.4K Hold
10,817
– – 0.01% 120
2025
Q1 		$28.9K Hold
10,817
– – 0.01% 118
2024
Q4 		$38.1K Hold
10,817
– – 0.01% 119
2024
Q3 		$51.3K Buy
+10,817
New +$49.4K 0.01% 119

Other funds holding ACHV

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
MF
Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return
MW
Members Wealth Media, Pennsylvania $182M AUM 15.09% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Windsor Capital Management's ACHV Position: Q2 2026 in Review

Windsor Capital Management held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 10,817 shares worth $70.6K. The position accounts for 0.02% of the portfolio, ranked #127.

Windsor Capital Management first reported a position in ACHV in Q3 2024 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Windsor Capital Management held 10,817 shares of Achieve Life Sciences worth $70.6K as of Q2 2026.
  • Windsor Capital Management left its Achieve Life Sciences share count unchanged in Q2 2026.
  • Achieve Life Sciences made up 0.02% of Windsor Capital Management's portfolio in Q2 2026, its #127 holding.
  • Windsor Capital Management first reported a position in Achieve Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • 11 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.